Loading company…
Paratus Sciences researches bat biology to discover medicines and support human health security.
Founded in 2021, Paratus Sciences uses research on bat biology to identify and develop medicines for human disorders. Its discovery platform draws on sequencing, bioinformatics, machine learning, stem cells, and comparative genetics. Based in New York, US, the company raised USD 100 million in Series A funding in February 2023 from Arch Venture Partners, Clavystbio, EcoR1 Capital, Leaps by Bayer, Polaris Partners, and Alexandria Venture Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in